Coordinating Swine Genome Editing Testing Center
Official title: Coordination: Swine Somatic Cell Gene Editing Testing Center
Funded at University of Missouri-Columbia · NIH-11393740 · Data updated 2026-11-12
A center at a major university coordinates testing of swine genome editing tools to help researchers create swine models with human genome targets.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Missouri-Columbia NIH-funded |
| Lab location | 1 site (Columbia, United States) |
| Project start | September 12, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $238,844 |
| NIH project number | 5U42OD035738-04 |
| Project ID | NIH-11393740 on NIH RePORTER |
Who could benefit from this research
✓Could help
Not applicable (facility and coordination grant; no direct patient enrollment).
✕Less likely to help
Patients are not directly recruited or enrolled in this coordination project.
What this research studies
This grant funds a centralized team that organizes communication, reporting, and logistics for Swine SCGE Center activities. It supports safety and efficacy assessments of somatic genome editing reagents in health and disease models. The center also develops and refines standard operating procedures and offers testing services to the research community. By coordinating collaborations and ensuring regulatory compliance, it helps accelerate translation of genome editing work into practical health research using pig models.
Why it matters
Potential benefit: If successful, the center could streamline responsible swine genome editing research and improve models for studying human diseases.
How similar studies have gone: Similar genome editing coordination efforts have shown value in improving collaboration and regulatory alignment in animal-model research.
Where this research is happening
-
University of Missouri-Columbia
Columbia, United States Active
Researchers
- Principal investigator: Wells, Kevin Dale — University of Missouri-Columbia
- Study coordinator: Wells, Kevin Dale
Related research
Other NIH-funded projects on the same topics.
-
Boosting immune response to fight cancer
This study is exploring a new way to help your immune system better fight cancer by tweaking certain cells in your body, and it aims to improve treatment for people with advanced cancer.
-
Interface between immune cells and scarring in the eye
This grant looks at how immune cells influence scar formation in the cornea after injury and how this affects vision.
-
Understanding cell-cleanup problems in C9ORF72-related ALS/FTD
Researchers are studying why the body's cell-cleanup systems fail in a genetic form of ALS/FTD to pave the way for better treatments.
-
Molecular clues to endometriosis-related infertility
This grant explores how molecular changes in endometriosis contribute to infertility, with the aim of finding better ways to diagnose and treat the condition.
-
A universal Shigella vaccine using SAVE to protect people of all ages
A new vaccine approach called SAVE aims to prevent Shigella-related dysentery across all ages, including children and adults, by targeting conserved bacterial components.
-
Biomarkers that predict osteoarthritis risk in people at higher risk
A long-term study will look for protein markers in body fluids that could predict who will develop knee osteoarthritis before symptoms appear.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.